Skip to main content

Biopharmaceutic studies

(Previously Guidance 15: Biopharmaceutic studies)

Guidance on bioavailability and/or bioequivalence aspects of prescription medicines including information on biowaivers.

Last updated

Help us improve the Therapeutic Goods Administration site